Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0P91
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,164
Award facts
- Contract value 100% obligated
- $2,164.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,164.46 by the Defense Logistics Agency on January 12, 2026. This delivery order falls under the company's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract (SPE2DR), which was established on November 13, 2025, with a $499.999 billion ceiling and extends through December 31, 2036. The delivery order utilizes firm fixed pricing with no set-aside designation and requires performance in Park Ridge, Illinois, with an ultimate completion date of January 13, 2026.
The PPV-G GEN V represents a comprehensive $30.3 billion federal acquisition strategy through which the Defense Logistics Agency procures a broad spectrum of pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. Under this vehicle, DMS Pharmaceutical Group has demonstrated substantial contracting activity, supplying an extensive portfolio including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices to military healthcare facilities. The company's prime vendor status within the Medical Supply Chain division positions it as a critical supplier capable of fulfilling the diverse pharmaceutical requirements of the federal military medical system across multiple therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DU26F0P91?
SPE2DU26F0P91 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DU26F0P91 worth?
The government has obligated $2,164 on SPE2DU26F0P91.
Is contract SPE2DU26F0P91 an order under another contract?
Yes. SPE2DU26F0P91 is a delivery order under SPE2DU25D9803, an indefinite delivery contract.
Was contract SPE2DU26F0P91 competed?
The extent of competition for SPE2DU26F0P91 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award